Literature DB >> 7541275

Cytokeratin expression in non-neoplastic oesophageal epithelium and squamous cell carcinoma of the oesophagus.

K Y Lam1, S L Loke, X C Shen, L T Ma.   

Abstract

The expression of cytokeratins (CK) 19, 8, 18, 13, 10 and 7 was examined in 35 cases of squamous cell carcinomas of the oesophagus (10 well-differentiated, 13 moderately-differentiated, and 12 poorly-differentiated) and the adjacent mucosa by means of a panel of monoclonal antibodies on frozen sections. The study was undertaken to assess the pattern of expression of these keratins in oesophageal tumours and its relation to the degree of differentiation. The normal oesophageal epithelia expressed CK19 in 86%, CK18 in 17% and CK13 in 14% of cases. CK8, CK10 and CK7 immunoreactivity was not observed. The tumours expressed CK19 in 86%, CK8 in 46%, CK18 in 97%, CK13 in 83%, CK10 in 34% and CK7 in 29% of cases. Thus, the so-called simple epithelial markers CK18 and CK19 occurred in the majority of oesophageal squamous cell carcinomas. CK13 (the so-called non-keratinizing squamous epithelial marker) was only infrequently demonstrated in the non-neoplastic oesophageal mucosa, and its expression was more frequent in carcinomas. CK10 was not demonstrated in non-neoplastic mucosa, but was mostly associated with well-differentiated carcinomas. We therefore conclude that the pattern of expression of cytokeratins in oesophageal carcinomas is different from that in normal oesophageal epithelia and varies with differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541275     DOI: 10.1007/bf00191342

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  16 in total

1.  Keratin expression in normal esophageal epithelium and squamous cell carcinoma of the esophagus.

Authors:  M P Grace; K H Kim; L D True; E Fuchs
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

2.  Estimates of the worldwide frequency of sixteen major cancers in 1980.

Authors:  D M Parkin; E Läärä; C S Muir
Journal:  Int J Cancer       Date:  1988-02-15       Impact factor: 7.396

3.  NCL-5D3: a new monoclonal antibody recognizing low molecular weight cytokeratins effective for immunohistochemistry using fixed paraffin-embedded tissue.

Authors:  B Angus; J Purvis; D Stock; B R Westley; A C Samson; E G Routledge; F H Carpenter; C H Horne
Journal:  J Pathol       Date:  1987-12       Impact factor: 7.996

4.  Immunohistochemistry of dysplasias and carcinomas of the esophageal epithelium.

Authors:  J Hurlimann; D Gardiol
Journal:  Pathol Res Pract       Date:  1989-06       Impact factor: 3.250

5.  Expression of keratin 13 in human epithelial neoplasms.

Authors:  M J Malecha; M Miettinen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

6.  Increased expression of cytokeratins 8, 18 and vimentin in the invasion front of mucosal squamous cell carcinoma.

Authors:  H E Schaafsma; L A Van Der Velden; J J Manni; H Peters; M Link; D J Rutter; F C Ramaekers
Journal:  J Pathol       Date:  1993-05       Impact factor: 7.996

7.  Histochemistry of mucin secreting components in mucoepidermoid and adenosquamous carcinoma of the oesophagus.

Authors:  K Y Lam; S L Loke; L T Ma
Journal:  J Clin Pathol       Date:  1993-11       Impact factor: 3.411

8.  Squamous cell carcinomas. An immunohistochemical study of cytokeratins and involucrin in primary and metastatic tumours.

Authors:  Z Suo; R Holm; J M Nesland
Journal:  Histopathology       Date:  1993-07       Impact factor: 5.087

9.  Aberrant expression of keratin proteins and cross-linked envelopes in human esophageal carcinomas.

Authors:  S P Banks-Schlegel; C C Harris
Journal:  Cancer Res       Date:  1984-03       Impact factor: 12.701

10.  Complex cytokeratin polypeptide patterns observed in certain human carcinomas.

Authors:  R Moll; R Krepler; W W Franke
Journal:  Differentiation       Date:  1983       Impact factor: 3.880

View more
  8 in total

1.  Squamous cell carcinoma in Barrett's esophagus: field effect versus metastasis.

Authors:  M M Streppel; P D Siersema; W W de Leng; F H Morsink; F P Vleggaar; A Maitra; E A Montgomery; G J Offerhaus
Journal:  Dis Esophagus       Date:  2012-01-03       Impact factor: 3.429

2.  Cytokeratin immunoexpression in esophageal squamous cell carcinoma of high-risk population in Northeast India.

Authors:  Avninder Singh; Sujala Kapur; Indranil Chattopadhyay; Joydeep Purkayastha; Jagannath Sharma; Ashwani Mishra; Stephen M Hewitt; Sunita Saxena
Journal:  Appl Immunohistochem Mol Morphol       Date:  2009-10

3.  Keratin 8 expression in head and neck epithelia.

Authors:  Christoph Matthias; Brigitte Mack; Alexander Berghaus; Olivier Gires
Journal:  BMC Cancer       Date:  2008-09-22       Impact factor: 4.430

4.  High expression of cytokeratin CAM5.2 in esophageal squamous cell carcinoma is associated with poor prognosis.

Authors:  Shujin He; Jie Peng; Lei Li; Ying Xu; Xiaoxiao Wu; Juan Yu; Jianli Liu; Jinguo Zhang; Renya Zhang; Wei Wang
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

5.  Circulating uPA as a potential prognostic biomarker for resectable esophageal squamous cell carcinoma.

Authors:  Xiao He; Xiaoling Xu; Guanxia Zhu; Hong Ye
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

6.  The Expressions of Keratins and P63 in Primary Squamous Cell Carcinoma of the Thyroid Gland: An Application of Raman Spectroscopy.

Authors:  Si-Si Wang; Dao-Xiong Ye; Bo Wang; Chao Xie
Journal:  Onco Targets Ther       Date:  2020-01-20       Impact factor: 4.147

7.  Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus.

Authors:  T Makino; M Yamasaki; A Takeno; M Shirakawa; H Miyata; S Takiguchi; K Nakajima; Y Fujiwara; T Nishida; N Matsuura; M Mori; Y Doki
Journal:  Br J Cancer       Date:  2009-09-15       Impact factor: 7.640

8.  Use of immunohistochemical analysis of CK5/6, CK14, and CK34betaE12 in the differential diagnosis of solid papillary carcinoma in situ from intraductal papilloma with usual ductal hyperplasia of the breast.

Authors:  Ichiro Maeda; Shinya Tajima; Yoshihide Kanemaki; Koichiro Tsugawa; Masayuki Takagi
Journal:  SAGE Open Med       Date:  2018-11-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.